Pharmacologic strategies for post-transplant maintenance in acute myeloid leukemia: it is time to consider!
I Abou Dalle, J El Cheikh, A Bazarbachi - Cancers, 2022 - mdpi.com
Simple Summary Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially
curative therapeutic procedure for patients with high risk acute myeloid leukemia. Its anti …
curative therapeutic procedure for patients with high risk acute myeloid leukemia. Its anti …
Maintenance therapy after allogeneic hematopoietic transplant for acute myeloid leukemia: a systematic review and meta-analysis
O Pasvolsky, S Shimony, M Yeshurun, L Shargian… - Acta …, 2021 - Taylor & Francis
Background For patients undergoing allogeneic hematopoietic stem cell transplant (HSCT)
for acute myeloid leukemia (AML), disease relapse remains the most common reason for …
for acute myeloid leukemia (AML), disease relapse remains the most common reason for …
Prophylactic or preemptive low-dose azacitidine and donor lymphocyte infusion to prevent disease relapse following allogeneic transplantation in patients with high …
T Guillaume, S Thépot, P Peterlin, P Ceballos… - … and Cellular Therapy, 2021 - Elsevier
Because of the persistently high rates of relapse of patients with high-risk acute
myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) following allogeneic …
myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) following allogeneic …
Case report: preemptive treatment with low-dose PD-1 blockade and azacitidine for molecular relapsed acute myeloid leukemia with RUNX1-runx1t1 after allogeneic …
Y Tang, Z Zhou, H Yan, Y You - Frontiers in Immunology, 2022 - frontiersin.org
Acute myeloid leukemia (AML) patients who develop hematological relapse (HR) after
allogeneic hematopoietic stem cell transplantation (allo-HSCT) generally have dismal …
allogeneic hematopoietic stem cell transplantation (allo-HSCT) generally have dismal …
Synergistic effects of 3D chitosan‐based hybrid scaffolds and mesenchymal stem cells in orthopaedic tissue engineering
P Qi, Z Ning, X Zhang - IET nanobiotechnology, 2023 - Wiley Online Library
Restoration of damaged bone and cartilage tissue with biomaterial scaffolds is an area of
interest in orthopaedics. Chitosan is among the low‐cost biomaterials used as scaffolds with …
interest in orthopaedics. Chitosan is among the low‐cost biomaterials used as scaffolds with …
[HTML][HTML] CDC45 modulates MCM7 expression and inhibits cell proliferation by suppressing the PI3K/AKT pathway in acute myeloid leukemia
R Zhang, Z Liu, G Zhang - American journal of translational …, 2021 - ncbi.nlm.nih.gov
CDC45 modulates MCM7 expression and inhibits cell proliferation by suppressing the PI3K/AKT
pathway in acute myeloid leukemia - PMC Back to Top Skip to main content NIH NLM Logo …
pathway in acute myeloid leukemia - PMC Back to Top Skip to main content NIH NLM Logo …
Pre‐transplant minimal residual disease assessment and transplant‐related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic …
We studied pretransplant minimal residual disease (MRD) in 224 patients (median age 44
years; range 17‐65) with acute myeloid leukemia (AML) undergoing allogeneic stem cell …
years; range 17‐65) with acute myeloid leukemia (AML) undergoing allogeneic stem cell …
Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia—Literature Review and Discussion of Possible Use in Relapse after …
Ø Bruserud, G Tsykunova, M Hernandez-Valladares… - Pharmaceuticals, 2021 - mdpi.com
Even though allogeneic stem cell transplantation is the most intensive treatment for acute
myeloid leukemia (AML), chemo-resistant leukemia relapse is still one of the most common …
myeloid leukemia (AML), chemo-resistant leukemia relapse is still one of the most common …
Challenges in the management of operable triple-negative breast cancer in a survivor of the B-cell acute lymphoblastic leukaemia: a case report
T Pavlin, A Blatnik, B Seruga - Frontiers in Oncology, 2024 - frontiersin.org
Background: Operable triple-negative breast cancer (TNBC) is an unfavourable subtype of
breast cancer which usually requires an aggressive perioperative systemic treatment. When …
breast cancer which usually requires an aggressive perioperative systemic treatment. When …
The role of immune checkpoint blockade in acute myeloid leukemia
M Silva, D Martins, F Mendes - Onco, 2022 - mdpi.com
Simple Summary Acute myeloid leukemia is an aggressive and very lethal blood tumor. It
represents a substantial percentage of leukemia patients, as well as leukemic deaths. The …
represents a substantial percentage of leukemia patients, as well as leukemic deaths. The …